Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 1/20 | 0.51 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4103033 | 0.85 | POLB (0.56) | SRD5A2MAOBL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4093376 | 0.85 | CYP3A4 (0.45) | SMN1; SMN2ALDH1A1HTTNPC1POLB | |
| SCHEMBL4102751 | 0.83 | MAOB (0.49) | SRD5A2MAOBL3MBTL1SMN1; SMN2HTT | |
| SCHEMBL4092308 | 0.82 | HTT (0.56) | SRD5A2MAOBL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL4102816 | 0.81 | MAPT (0.58) | POLBTP53MAPTFFAR1PPARG | |
| SCHEMBL1390921 | 0.80 | HPGD (0.46) | MAOBL3MBTL1ALDH1A1RAB9ANPC1 | |
| SCHEMBL3998488 | 0.79 | SRD5A2 (0.58) | SRD5A2MAOBL3MBTL1SMN1; SMN2ALDH1A1 | |
| SCHEMBL26047475 | 0.78 | HDAC8 (0.49) | MAOBL3MBTL1SMN1; SMN2RAB9ANPC1 | |
| SCHEMBL12553520 | 0.78 | CYP3A4 (0.47) | MAOBSMN1; SMN2ALDH1A1HTTRAB9A | |
| SCHEMBL4102407 | 0.76 | KMT2A (0.49) | SMN1; SMN2ALDH1A1HTTPOLBTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1911738-A1 | PHENOXYALKANOIC ACID COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2008-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054435-A1 | Phenoxyalkanoic Acid Compound | PNLIP, GPR119, LIPC | SRD5A2 1533/4885MAOB 3361/4885L3MBTL1 1870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.